Is epidermal growth factor present in human blood? Interference with the radioreceptor assay for epidermal growth factor.
Human whole blood serum reduces the binding of [125I]labeled mouse epidermal growth factor to cultured human fibroblasts as well as does 70-100 ng/ml mouse epidermal growth factor. However, at most 1-2% of the binding inhibitor detected in human whole blood serum is related to epidermal growth factor--the remaining consists of other factors released during preparation of serum, predominantly the platelet-derived growth factor, which are capable of altering the binding properties of the epidermal growth factor receptor. This accounts for much of the differences between values reported for epidermal growth factor concentration in blood by investigators using different assay procedures.
D001667:Binding, Competitive; D004815:Epidermal Growth Factor / Q000097:blood*; D066246:ErbB Receptors; D005347:Fibroblasts; D006133:Growth Substances / Q000378:metabolism; D006801:Humans; D011869:Radioligand Assay; D011956:Receptors, Cell Surface / Q000378:metabolism
D006133:Growth Substances; D011956:Receptors, Cell Surface; D004815:Epidermal Growth Factor; D066246:ErbB Receptors